Kerstin Locher

Kerstin Locher

Auto-generated profile, based on publicly available information

Kerstin Locher

Division of Medical Microbiology, Vancouver General Hospital , Vancouver, British Columbia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
ICInduja Chandrakumar
Induja Chandrakumar
NGNick P. G. Gauthier
Nick P. G. Gauthier
CNCassidy Nelson
Cassidy Nelson
MBMichael B. Bonsall
Michael B. Bonsall
KLKerstin Locher
Kerstin Locher
SCSamuel Chorlton
Samuel Chorlton
A large gap remains between sequencing a microbial community and characterizing all of the organisms inside of it. Here we develop a novel method to taxonomically bin metagenomic assemblies through alignment of contigs against a reference database. We show that this workflow, BugSplit, bins metagenome-assembled contigs to species with a 33% absolute improvement in F1-score when compared to alternative tools. We perform nanopore mNGS on patients with COVID-19, and using a reference database predating COVID-19, demonstrate that BugSplit’s taxonomic binning enables sensitive and specific detection of a novel coronavirus not possible with other approaches. When applied to nanopore mNGS data from cases ofKlebsiella pneumoniaeandNeisseria gonorrhoeaeinfection, BugSplit’s taxonomic binning accurately separates pathogen sequences from those of the host and microbiota, and unlocks the possibility of sequence typing, in silico serotyping, and antimicrobial resistance prediction of each organism within a sample. BugSplit is available athttps://bugseq.com/academic.

2 May 2024 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
NGNick P G Gauthier
Nick P G Gauthier
WCWilson Chan
Wilson Chan
KLKerstin Locher
Kerstin Locher
DSDuane Smailus
Duane Smailus
RCRobin Coope
Robin Coope
AMAmee R Manges
Amee R Manges
Current molecular diagnostics are limited in the number and type of detectable pathogens. Metagenomic next generation sequencing (mNGS) is an emerging, and increasingly feasible, pathogen-agnostic diagnostic approach. Translational barriers prohibit the widespread adoption of this technology in clinical laboratories. We validate an end-to-end mNGS assay for detection of respiratory viruses. Our assay is optimized to reduce turnaround time, lower cost-per-sample, increase throughput, and deploy secure and actionable bioinformatic results. We validated our assay using residual nasopharyngeal swab specimens from Vancouver General Hospital (n = 359), RT-PCR-positive, or negative for Influenza, SARS-CoV-2, and RSV. We quantified sample stability, assay precision, the effect of background nucleic acid levels, and analytical limits of detection. Diagnostic performance metrics were estimated. We report that our mNGS assay is highly precise, semi-quantitative, with analytical limits of detection ranging from 103-104 copies/mL. Our assay is highly specific (100%) and sensitive (61.9% Overall: 86.8%; RT-PCR Ct < 30). Multiplexing capabilities enable processing of up to 55-specimens simultaneously on an Oxford Nanopore GridION device, with results reported within 12-hours. This study outlines the diagnostic performance and feasibility of mNGS for respiratory viral diagnostics, infection control, and public health surveillance. We addressed translational barriers to widespread mNGS adoption.

13 March 2024 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
CDClaudine Desruisseaux
Claudine Desruisseaux
CBConor Broderick
Conor Broderick
VLValéry Lavergne
Valéry Lavergne
KSKim Sy
Kim Sy
DGDuang-Jai Garcia
Duang-Jai Garcia
MCMarthe K. Charles
Marthe K. Charles
This study aimed to validate Metasystems’ automated acid-fast bacilli (AFB) smear microscopy scanning and deep-learning-based image analysis module (Neon Metafer) with assistance on respiratory and pleural samples, compared to conventional manual fluorescence microscopy (MM). Analytical parameters were assessed first, followed by a retrospective validation study. In all, 320 archived auramine-O-stained slides selected non-consecutively [85 originally reported as AFB-smear-positive, 235 AFB-smear-negative slides; with an overall mycobacterial culture positivity rate of 24.1% (77/320)] underwent whole-slide imaging and were analyzed by the Metafer Neon AFB Module (version 4.3.130) using a predetermined probability threshold (PT) for AFB detection of 96%. Digital slides were then examined by a trained reviewer blinded to previous AFB smear and culture results, for the final interpretation of assisted digital microscopy (a-DM). Paired results from both microscopic methods were compared to mycobacterial culture. A scanning failure rate of 10.6% (34/320) was observed, leaving 286 slides for analysis. After discrepant analysis, concordance, positive and negative agreements were 95.5% (95%CI, 92.4%–97.6%), 96.2% (95%CI, 89.2%–99.2%), and 95.2% (95%CI, 91.3%–97.7%), respectively. Using mycobacterial culture as reference standard, a-DM and MM had comparable sensitivities: 90.7% (95%CI, 81.7%–96.2%) versus 92.0% (95%CI, 83.4%–97.0%) ( P -value = 1.00); while their specificities differed 91.9% (95%CI, 87.4%–95.2%) versus 95.7% (95%CI, 92.1%–98.0%), respectively ( P -value = 0.03). Using a PT of 96%, MetaSystems’ platform shows acceptable performance. With a national laboratory staff shortage and a local low mycobacterial infection rate, this instrument when combined with culture, can reliably triage-negative AFB-smear respiratory slides and identify positive slides requiring manual confirmation and semi-quantification. IMPORTANCE: This manuscript presents a full validation of MetaSystems’ automated acid-fast bacilli (AFB) smear microscopy scanning and deep-learning-based image analysis module using a probability threshold of 96% including accuracy, precision studies, and evaluation of limit of AFB detection on respiratory samples when the technology is used with assistance. This study is complementary to the conversation started by Tomasello et al. on the use of image analysis artificial intelligence software in routine mycobacterial diagnostic activities within the context of high-throughput laboratories with low incidence of tuberculosis.

27 April 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
KLKerstin Locher
Kerstin Locher
CBCorrie R. Belanger
Corrie R. Belanger
EEEric Eckbo
Eric Eckbo
MCMelissa Caza
Melissa Caza
BVBillie Velapatino
Billie Velapatino
MCMarthe K. Charles
Marthe K. Charles
Sanger sequencing of the 16S rRNA gene is widely used as a diagnostic tool for bacterial identification, especially in cases where routine diagnostic methods fail to provide an identification, for organisms that are difficult to culture, or from specimens where cultures remain negative. Our simplified protocol is tailored toward use in frontline laboratories with little to no experience with sequencing.

1 December 2019 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
KLKerstin Locher
Kerstin Locher
DRDiane Roscoe
Diane Roscoe
AJAgatha Jassem
Agatha Jassem
TWTitus Wong
Titus Wong
LHLinda M.N. Hoang
Linda M.N. Hoang
ASAleksandra Stefanovic
Aleksandra Stefanovic

17 August 2023 in Microbiology Spectrum
Verified
Journal Article
Open access
CBCorrie R. Belanger
Corrie R. Belanger
KLKerstin Locher
Kerstin Locher
BVBillie Velapatino
Billie Velapatino
PDPhilippe J. Dufresne
Philippe J. Dufresne
EEEric Eckbo
Eric Eckbo
MCMarthe Charles
Marthe Charles
Pneumonia, caused by the opportunistic fungus Pneumocystis jirovecii , poses a significant risk for immunocompromised individuals. Laboratory testing for P. jirovecii is progressively shifting toward the use of molecular tests such as real-time PCR; however, this is often performed at reference laboratories.